Evidence map›Paper›PMID 26885236›Full record

ArticleInternational journal of clinical and experimental medicine2015

Clinicopathological associations of acquired erythroblastopenia.

Gursel Gunes, Umit Yavuz Malkan, Hatime Arzu Yasar, Eylem Eliacik, Ibrahim Celalettin Haznedaroglu, Haluk Demiroglu, Nilgun Sayinalp, Salih Aksu, Sezgin Etgul, Tuncay Aslan and 3 more

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Human herpesvirus type 7 and bone marrow disorders: a new association to consider in relation with a case report.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Gursel GunesDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Umit Yavuz MalkanDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Hatime Arzu YasarDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Eylem EliacikDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Ibrahim Celalettin HaznedarogluDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Haluk DemirogluDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Nilgun SayinalpDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Salih AksuDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Sezgin EtgulDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Tuncay AslanDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Hakan GokerDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Osman Ilhami OzcebeDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Yahya BuyukasikDepartment of Internal Medicine, Division of Hematology, School of Medicine, Hacettepe University Turkey.
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcquired erythroblastopenia (AE) is a rare clinical situation. It is characterized by the reduction of erythroid precursors in the bone marrow together with the low reticulocyte counts in the peripheral blood.

backgroundMain secondary causes of AE are drugs, Parvovirus B19 and other infectious reasons, lymphoid and myeloid neoplasia, autoimmune diseases, thymoma and pregnancy. The aim of this study is to assess the frequencies and clinical associations of AE via analyzing 12340 bone marrow samples in a retrospective manner. MATERIAL AND

methodBone marrow aspirations which were obtained from patients who applied to Hacettepe University Hematology Clinic between 2002 and 2013, were analyzed retrospectively.

resultsThirty four erythroblastopenia cases were found. Patients ranged in age from 16 to 80 years with a median of 38 years. Fifteen patients were men (44%) and nineteen were women (56%). In these patients, detected causes of erythroblastopenia were MDS, idiopathic pure red cell aplasia (PRCA), parvovirus infection, post chemotherapy aplasia, plasma proliferative diseases, copper deficiency due to secondary amyloidosis, fever of unknown origin, hemophagocytic syndrome, enteric fever and legionella pneumonia. We found that between those reasons the most common causes of erythroblastopenia are MDS (17.7%) and idiopathic PRCA (17.7%). DISCUSSION: As a result, erythroblastopenia in the bone marrow may be an early sign of MDS. In those AE cases possibility of being MDS must be kept in mind as it can be mistaken for PRCA.

conclusionTo conclude, in adults MDS without excess blast is one of the most common causes of erythroblastopenia in clinical practice and in case of erythroblastopenia the presence of MDS should be investigated.

Indexed as

Erythroblastopeniamyelodisplastic syndromepure red cell aplasia

Identifiers

PMID26885236
PMCPMC4730022
OpenAlexW2407721086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.